Up to 97% of NAION patients have small optic discs with small or absent cups, representing the strongest risk factor
sdLDL is considerably more atherogenic than standard fluffy LDL and a potent risk factor for coronary atherosclerosis
These agents include: Tirzepatide (Mounjaro, Zepbound though technically a dual GIP/GLP-1 receptor agonist) Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) They are widely used in both endocrinology and obesity medicine for managing diabetes, weight, and cardiovascular risk
Theyre broadly understood to work by inhibiting hunger and slowing the passage of food from the stomacheffects that sound benign, as if the drugs were little more than pharmacological versions of a fiber-rich diet
Today, I look forward to my morning bowl of oatmeal or yogurt
With smaller portions and skipped meals, protein often becomes the unintended casualty